Fundraising Fox

Tekedia Capital β€” 2026 Investments

5 investments dated 2026 Β· listed companies and verified rows first Β· show all

Anto Biosciencesanto.bioin𝕏Jun 2026

Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Arvid E. Gollwitzer(Founder)inDavid de Gruijl(Founder)in

Co-investorsRRE VenturesY Combinator

Corgi Insurancecorgi.comin𝕏Jan 2026 Β· $108M

Corgi is an AI-native, full-stack insurance platform that serves technology companies.

AI & Machine LearningEnterprise SoftwareFintechInsurTechSaaSSan Francisco, US

Nico Laqua(Founder)inEmily Yuan(Founder)inNicolas Laqua(Executive Officer, Director)Emily Zeng Yuan(Executive Officer, Director)

BoardAlexander Wortmann(Director)Oliver Jung(Director)

Co-investorsOrange CollectiveY CombinatorAlumni VenturesContraryFIRST ORDERGlade Brook Capital Partners+7 more

General Astronauticsgeneralastro.comin𝕏Jun 2026

General Astronautics develops robotic systems designed for research and manufacturing applications in microgravity environments.

Advanced ManufacturingSpace TechSan Francisco, US

Bram Schork(Founder & CEO)in

Co-investorsY Combinator

Kalpa Labskalpalabs.aiin𝕏Jun 2026

Kalpa Labs develops generalist audio models capable of following instructions and learning new tasks in context, with initial applications in conversational speech synthesis.

AI & Machine LearningEnterprise SoftwareSan Francisco, US

Prashant Shishodia(Founder)inGautam Jha(Founder)in

Co-investorsY Combinator

Mango Medicalmangomedical.ioinJun 2026

Mango Medical develops AI systems that generate customized surgical plans for orthopedic procedures, producing detailed recommendations in minutes rather than requiring days of manual planning.

Healthtech

Adrian Kilian(Founder & CEO)inJorge Padilla Perez(Founder)in

Co-investorsY Combinator

Rows marked β€œSEC filing” are inferred from directors named on the company's SEC Form D β€” public regulatory data, not a portfolio list published by the firm.